Bcl-2 protection of islet allografts is unmasked by costimulation blockade

Transplantation

Volumn 77, Issue 10, 2004, Pages 1610-1613

  Sutherland, Robyn M ^a   Allison, Janette ^b   Thomas, Helen E ^a,c   Brady, Jamie L ^a   Kay, Thomas W H ^a,c   Lew, Andrew M ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INSULIN; PROTEIN BCL 2;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DONOR; GRAFT PRESERVATION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION;

ANIMALS; APOPTOSIS; CYCLIN D1; CYTOPROTECTION; DIABETES MELLITUS; GRAFT SURVIVAL; IMMUNOCONJUGATES; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 2542578585     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000132283.95107.9C     Document Type: Article

References (10)

1. Dupraz P, Rinsch C, Pralong WF, et al. Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokineinduced apoptosis while preserving in vitro and in vivo control of insulin secretion. Gene Ther 1999; 6(6): 1160.
2. Contreras JL, Bilbao G, Smyth CA, et al. Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene. Transplantation 2001; 71(8): 1015.
3. Rabinovitch A, Suarez-Pinzon W, Strynadka K, et al. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 1999; 48(6): 1223.
4. Liu Y, Rabinovitch A, Suarez-Pinzon W, et al. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis. Hum Gene Ther 1996; 7(14): 1719.
5. Benhamou PY. Immunomodulation with CTLA4-Ig in islet transplantation. Transplantation 2002; 73 (1 Suppl): S40.
6. Allison J, Thomas H, Beck D, et al. Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction. Int Immunol 2000; 12(1): 9.
7. Marsden VS, Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 2003; 21: 71.
8. Sutherland RM, Mountford JN, Allison J, et al. The non-immune RIP-Kb mouse is a useful host for islet transplantation, as the diabetes is spontaneous, mild and predictable. Int J Exp Diabetes Res 2002; 3(1): 37.
9. Sutherland RM, Brady JL, Georgiou HM, et al. Protective effect of CTLA41g secreted by transgenic fetal pancreas allografts. Transplantation 2000; 69(9): 1806.
10. Diamond AS, Gill RG. An essential contribution by IFN-gamma to CD8+ T cell-rejection of pancreatic islet allografts. J Immunol 2000; 165(1): 247.